These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Preliminary results and considerations of the use of amphotericin B in topical therapy of mycotic vulvovaginitis]. Bortolozzi G Ann Ostet Ginecol Med Perinat; 1970 Mar; 92(3):192-204. PubMed ID: 5535562 [No Abstract] [Full Text] [Related]
6. Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia. Cudillo L; Tendas A; Picardi A; Dentamaro T; Del Principe MI; Amadori S; de Fabritiis P Ann Hematol; 2006 Feb; 85(2):136-8. PubMed ID: 16220312 [No Abstract] [Full Text] [Related]
8. Mortality rates in comparative trials of formulations of amphotericin B. Frothingham R Clin Infect Dis; 2001 Aug; 33(4):582-3. PubMed ID: 11462201 [No Abstract] [Full Text] [Related]
9. Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B. Krüger WH; Kröger N; Rüssmann B; Renges H; Kabisch H; Zander AR Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S10-3. PubMed ID: 9916623 [TBL] [Abstract][Full Text] [Related]
10. [Amphotericin B: the end of an era]. Oude Lashof AM; Kullberg BJ Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1665-8. PubMed ID: 15453116 [TBL] [Abstract][Full Text] [Related]
12. AmBisome: adds to the body of knowledge and familiarity of use. Richardson M Acta Biomed; 2006; 77 Suppl 4():3-11. PubMed ID: 17370564 [No Abstract] [Full Text] [Related]
13. [Must we be really concerned about amphotericin B toxicity in oncology patients?]. Mayer J; Doubek M Cas Lek Cesk; 1998 Oct; 137(20):632-6. PubMed ID: 9863267 [TBL] [Abstract][Full Text] [Related]
15. Treatment of keratomycosis with amphotericin B. ointment. Chaddah MR; Aggarwal DC Indian J Ophthalmol; 1978 Apr; 26(1):9-11. PubMed ID: 711284 [No Abstract] [Full Text] [Related]
16. Liposome battle for antifungal market shifts into high gear. Marks S J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):46-7. PubMed ID: 11363518 [TBL] [Abstract][Full Text] [Related]
17. Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes. Garbino J; Markham L; Matulionyte R; Rives V; Lew D Scand J Infect Dis; 2006; 38(2):110-3. PubMed ID: 16449001 [TBL] [Abstract][Full Text] [Related]
18. [Amphotericin B: the end of an era]. van der Klooster JM; Zandstra DF Ned Tijdschr Geneeskd; 2005 Jan; 149(2):107-8; author reply 108. PubMed ID: 15688846 [No Abstract] [Full Text] [Related]
19. [Treatment of systemic mycoses]. Sandven P Tidsskr Nor Laegeforen; 1981 Sep; 101(27):1500-3. PubMed ID: 7336401 [No Abstract] [Full Text] [Related]
20. [Resolution of a disseminated infection by Fusarium solani in a patient with acute promyelocytic leukemia and granulocytopenia secondary to chemotherapy by the combined use of G-CSF and liposomal amphotericin B]. Sancho JM; Ribera JM; Matas L; Batlle M Med Clin (Barc); 1997 Jun; 109(4):156-7. PubMed ID: 9289532 [No Abstract] [Full Text] [Related] [Next] [New Search]